TARGTEPO
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for TARGTEPO, covering 2017-07-13 to 2018-10-30. Get the full timeline:
Most recent: Clinical Trial Update: TARGTEPO Treatment for Anemia in Chronic Kidney Disease (CKD) Patients and End-Stage Renal Disease (ESRD) [Phase 1, Phase 2]